NCT03042923View on ClinicalTrials.gov

Intestinal Permeability and Endometriosis

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Endometriosis
Interventions
DRUG

lactulose:mannitol (L:M) oral challenge

Trial Locations (2)

37403

Erlanger Medical Center, Chattanooga

37421

Women's Surgery Center, Chattanooga

All Listed Sponsors
lead

University of Tennessee

OTHER

NCT03042923 - Intestinal Permeability and Endometriosis | Biotech Hunter | Biotech Hunter